primary dysmenorrhea
Conditions
Interventions
Gynecological hot compress group:The gynecological hot compress will be stuck between the umbilicus and pubic symphysis, 2 times a day, 2 hours each time, continuous use for 28 days as a course of tre
Hot compress placebo group:the same as gynecological hot compress
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
Female
Age
16 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. It conforms to the diagnosis of primary dysmenorrhea in western medicine; 2. The VAS score of abdominal pain on the most painful day before menstruation or during menstruation in the last 3 months is = 4 points; 3. Symptoms of dysmenorrhea occurred continuously before or on the day of menstruation in recent 3 months; 4. Regular menstrual cycle: 21-35 days; menstrual period: 3-7 days; 5. Aged 16-35 (inclusive); 6. Voluntary participation in this clinical trial, informed consent and signing of informed consent.
Exclusion criteria
Exclusion criteria: 1. Secondary dysmenorrhea caused by endometriosis, adenomyosis, pelvic inflammatory diseases, etc; 2. Have used pain relievers such as non steroidal anti-inflammatory drugs or other methods to treat dysmenorrhea in the past month; 3. I have used traditional Chinese medicine and Chinese patent medicine with the function of regulating qi and removing blood stasis in the past month; 4. Blood creatinine (SCr)>upper limit of normal value, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) = 1.5 times of upper limit of normal reference value, or hemoglobin = 90g/L; 5. Gynecological tumor, hysteromyoma, abortion history, and gynecological surgery history; 6.6 Use of injectable or subcutaneous implantation of long-acting contraceptives within six months, or use of contraceptives and drug intrauterine devices within eight weeks, or preparation for pregnancy and pregnancy or lactation within six months; 7. Have bleeding tendency; 8. Complicated with serious primary diseases such as heart, brain, lung, liver, kidney, nervous system and hematopoietic system; 9. Mental retardation or psychosis or neurosis; 10. Suspect or have a history of alcohol and drug abuse; 11. Known or suspected to have a history of allergy to the ingredients and excipients of the test drug; 12. Asthma patients who are allergic to ibuprofen capsules or other non steroidal anti-inflammatory drugs or aspirin for emergency use; 13. Participated in other clinical trials in recent 3 months; 14. The investigator considers it inappropriate to participate in this clinical trial.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 11/5000 VAS score for dysmenorrhea;Duration of dysmenorrhea;The number of days with significant menstrual pain VAS=4;CMSS Score; | — |
Primary
| Measure | Time frame |
|---|---|
| Dysmenorrhea pain relief rate; | — |
Countries
China
Contacts
Public ContactYu Chaoqin
Naval Medical University
Outcome results
None listed